SXTC Financials
China Sxt Pharmaceuticals Inc - Financial statements & key metrics
Stock Price
$1.93
Market Cap
$1.78M
EPS
$-57.15
Income Statement Highlights
Most Recent Quarter: 2025-03-31
Revenue
$1.74M
Gross Profit
$367427.00
Operating Income
$-2.68M
Net Income
$-3.30M
EPS (Diluted)
$-
Balance Sheet Highlights
Total Assets
$21.66M
Total Liabilities
$6.22M
Shareholders Equity
$15.44M
Cash & Equivalents
$18.10M
Total Debt
-
Cash Flow Highlights
Operating Cash Flow
$-2.35M
CapEx
$2023
Free Cash Flow
$-2.35M
Profitability Metrics
Gross Margin
21.7%
Operating Margin
-10.1%
ROE
-0.5%
View Complete Financial Statements
Full income statements, balance sheets, and cash flows for multiple periods
Open Full FinancialsFrequently Asked Questions
What is SXTC revenue?
SXTC's most recent quarterly revenue was $1.74M. Annual revenue can be calculated by summing the four most recent quarters.
Is SXTC profitable?
SXTC reported a loss of $3.30M in the most recent quarter.
What is SXTC market cap?
SXTC has a market capitalization of $1.78M, making it a small-cap stock.
Does SXTC have debt?
View SXTC's balance sheet for debt information.
What is SXTC cash flow?
SXTC's most recent quarterly free cash flow was $-2.35M.